GENETICS × TECHNOLOGY

Stitching Genes Together

1973 CE

History · Contemporary · Holocene · Meghalayan

In 1973, Stanley Cohen and Herbert Boyer joined DNA from different organisms and grew the hybrid in bacteria: genes had become movable parts. The power frightened its own inventors; experiments were paused, and the 1975 Asilomar conference drafted the safety rules under which the work resumed. Within a few years the technique had a company, Genentech, and a product, human insulin grown in microbes, and the biotechnology industry existed.

Why it matters

Every engineered medicine, crop and industrial microbe descends from this splice, and so does the way society governs biology: Asilomar became the template, cited and contested, for scientists regulating their own inventions in public. The episode set the questions, who decides what is safe, who profits from living inventions, that CRISPR and synthetic biology still answer with the vocabulary written here.

Dating & uncertainty

Cohen and Boyer's recombinant technique dates to 1973, with the decisive cloning experiment run with John Morrow; the field's self-imposed pause and the Asilomar conference on its risks followed in 1975. Historians now read Asilomar less as a moment of resolved consensus than as the start of a long negotiation between safety, regulation and commerce that produced the biotechnology industry.

Sources

1. Yi (2025), Journal of the History of Biology · Asilomar, gene cloning's origins, and its commercial fatedoi:10.1007/s10739-025-09803-0
2. Hindmarsh & Gottweis (2005), Science as Culture · Recombinant regulation: the Asilomar legacy 30 years ondoi:10.1080/09505430500368949
3. Scheffler (2025), Journal of the History of Biology · Asilomar goes underground: the long legacy of recombinant DNA hazard debates for the Greater Boston Area biotechnology industrydoi:10.1007/s10739-025-09806-x

Our species’ history as one day

23:59:4514.5 s before midnight

if the 315,000 years of Homo sapiens were compressed into a single day